Fact CheckerSign in

NCT05828849Active, not recruiting

Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

Can a Radical Transformation of Preventive Care Reduce Mortality by 20% in Low Socioeconomic (SES) Populations? Preparatory Work Focusing on Alcohol Use Disorder (AUD)/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

Source: ClinicalTrials.gov · Last updated 3 Mar 2026

Brief summary (registry, in English)

The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) will help people reduce their chances of dying from preventable causes, including heart attacks, strokes, drinking alcohol, substance abuse, HIV, and other conditions.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
87 (actual)
First submitted
13 Apr 2023
Start date
25 Jun 2024
Primary completion date
31 Jul 2026
Lead sponsor
NYU Langone Health
Diseases
HIV
NCT number
NCT05828849

What you commit to

  • Study type: Interventional
  • Participants enrolled: 87
  • From 25 Jun 2024 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Already diagnosed with high mortality-condition(s) that are not included in the simulation model.

Other

  • Receives regular care elsewhere than Health and Hospitals Corporation of New York

Who the study is looking for

  • Age 35 to 64
  • Low SES (≤ $38,000 annual income, based on 2019 20th percentile NYC income, adjusted for family size)
  • Expected mortality ≥1% per year (based on age, sex, race/ethnicity), with ≥1 of the following contributors:
    • 10-year cardiovascular risk ≥10% (assessed by ASCVD risk tool)
    • Heavy alcohol consumption (defined using SAMHSA binge drinking definition, drinking \>4 standard drinks for men and \>3 standard drinks for women on same occasion in past month)
  • Willing to be navigated to Health and Hospitals Corporation of New York health system.
  • Ability to provide written informed consent in English or Spanish

Age in the registry: 35 years to 64 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYC H+H/Bellevue
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.